• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The International Association for the Study of Lung Cancer Molecular Database Project: Objectives, Challenges, and Opportunities.国际肺癌研究协会分子数据库项目：目标、挑战与机遇
J Thorac Oncol. 2021 Jun;16(6):897-901. doi: 10.1016/j.jtho.2021.03.003. Epub 2021 Mar 23.
2
The IASLC Lung Cancer Staging Project: A Renewed Call to Participation.IASLC 肺癌分期项目：再次呼吁参与。
J Thorac Oncol. 2018 Jun;13(6):801-809. doi: 10.1016/j.jtho.2018.02.012. Epub 2018 Feb 22.
3
Lung Carcinoma Staging Update.肺癌分期更新
Arch Pathol Lab Med. 2017 Jul;141(7):923-926. doi: 10.5858/arpa.2016-0387-RA. Epub 2016 Nov 28.
4
The IASLC Lung Cancer Staging Project: data elements for the prospective project.国际肺癌研究协会肺癌分期项目：前瞻性项目的数据要素
J Thorac Oncol. 2009 Jun;4(6):679-83. doi: 10.1097/JTO.0b013e3181a52370.
5
The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.国际肺癌研究协会分期项目：手术治疗的非小细胞肺癌的预后因素及病理TNM分期
J Thorac Oncol. 2009 Jul;4(7):792-801. doi: 10.1097/JTO.0b013e3181a7716e.
6
The IASLC Mesothelioma Staging Project: Improving Staging of a Rare Disease Through International Participation.IASLC 间皮瘤分期项目：通过国际参与改善罕见病分期。
J Thorac Oncol. 2016 Dec;11(12):2082-2088. doi: 10.1016/j.jtho.2016.09.123. Epub 2016 Sep 23.
7
The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer.国际肺癌研究协会肺癌分期项目：关于即将出版的（第七版）肺癌肿瘤、淋巴结、转移分类中对小细胞肺癌临床分期的建议。
J Thorac Oncol. 2007 Dec;2(12):1067-77. doi: 10.1097/JTO.0b013e31815bdc0d.
8
The new lung cancer staging system.新的肺癌分期系统。
Chest. 2009 Jul;136(1):260-271. doi: 10.1378/chest.08-0978.
9
The International Association for the Study of Lung Cancer--the Lung Cancer Staging Project: better data, better decisions, better outcomes.
Hawaii Med J. 2008 Aug;67(8):220-2.
10
The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours.国际肺癌研究协会肺癌分期项目：对即将出版的（第七版）恶性肿瘤TNM分类中T、N和M描述符修订提案及相应分期分组的验证。
J Thorac Oncol. 2007 Aug;2(8):694-705. doi: 10.1097/JTO.0b013e31812d05d5.

引用本文的文献

1
Recent Noteworthy Studies in Thoracic Oncology.近期胸部肿瘤学的重要研究
Ann Surg Oncol. 2025 Mar;32(3):1610-1616. doi: 10.1245/s10434-024-16353-y. Epub 2024 Oct 15.
2
Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.两种干预措施对基于人群的肺癌切除队列中病理性淋巴结分期的影响。
Ann Thorac Surg. 2024 Mar;117(3):576-584. doi: 10.1016/j.athoracsur.2023.08.026. Epub 2023 Sep 5.
3
Lung cancer surgery at present and tendency.肺癌手术的现状与趋势
Transl Cancer Res. 2022 Dec;11(12):4220-4222. doi: 10.21037/tcr-22-2342.
4
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Overview of Challenges and Opportunities in Revising the Nodal Classification of Lung Cancer.国际肺癌研究协会肺癌分期项目：修订肺癌淋巴结分类的挑战与机遇概述。
J Thorac Oncol. 2023 Apr;18(4):410-418. doi: 10.1016/j.jtho.2022.12.009. Epub 2022 Dec 24.
5
Tracheal fistula repair with stent placement after failure of reconstruction with muscle tissue. A lung cancer surgery complication.肌肉组织重建失败后行气管瘘修复并置入支架。一种肺癌手术并发症。
Respir Med Case Rep. 2021 Sep 21;34:101518. doi: 10.1016/j.rmcr.2021.101518. eCollection 2021.

本文引用的文献

1
Controversies in Thoracic Oncology.
J Thorac Oncol. 2021 Mar;16(3):366-367. doi: 10.1016/j.jtho.2021.02.002.
2
A Call to Arms: Reducing Disparities in Lung Cancer Care Worldwide.战斗号召：减少全球肺癌治疗的差距。
J Thorac Oncol. 2020 Nov;15(11):1700-1702. doi: 10.1016/j.jtho.2020.09.014. Epub 2020 Oct 23.
3
Osimertinib in Resected -Mutated Non-Small-Cell Lung Cancer.奥希替尼治疗可切除突变型非小细胞肺癌。
N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19.
4
The Effect of Advances in Lung-Cancer Treatment on Population Mortality.肺癌治疗进展对人群死亡率的影响。
N Engl J Med. 2020 Aug 13;383(7):640-649. doi: 10.1056/NEJMoa1916623.
5
Clinical Impacts of EGFR Mutation Status: Analysis of 5780 Surgically Resected Lung Cancer Cases.临床影响的 EGFR 突变状态：5780 例手术切除肺癌病例分析。
Ann Thorac Surg. 2021 Jan;111(1):269-276. doi: 10.1016/j.athoracsur.2020.05.041. Epub 2020 Jun 29.
6
The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer.国际肺癌研究协会肺癌分子检测全球调查。
J Thorac Oncol. 2020 Sep;15(9):1434-1448. doi: 10.1016/j.jtho.2020.05.002. Epub 2020 May 20.
7
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study.在 ALEX 研究中，未经治疗的晚期 ALK 阳性非小细胞肺癌患者的更新总生存和最终无进展生存数据。
Ann Oncol. 2020 Aug;31(8):1056-1064. doi: 10.1016/j.annonc.2020.04.478. Epub 2020 May 11.
8
Prognostic value and therapeutic implications of expanded molecular testing for resected early stage lung adenocarcinoma.早期肺腺癌切除术后扩大分子检测的预后价值及治疗意义。
Lung Cancer. 2020 May;143:60-66. doi: 10.1016/j.lungcan.2020.03.012. Epub 2020 Mar 18.
9
Cancer statistics, 2020.癌症统计数据，2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
10
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数：1990 至 2017 年全球疾病负担研究的系统分析。
JAMA Oncol. 2019 Dec 1;5(12):1749-1768. doi: 10.1001/jamaoncol.2019.2996.

The International Association for the Study of Lung Cancer Molecular Database Project: Objectives, Challenges, and Opportunities.

作者信息

Osarogiagbon Raymond U, Rami-Porta Ramon, Tsao Ming Sound, Montuenga Luis M, Nishimura Katherine K, Giroux Dorothy J, Travis William, Asamura Hisao, Rusch Valerie, Carbone David P, Hirsch Fred R

机构信息

Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.

Department of Thoracic Surgery, Hospital Universitari Mútua Terrassa, University of Barcelona, Terrassa, Spain; Network of Centers for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Spain.

出版信息

J Thorac Oncol. 2021 Jun;16(6):897-901. doi: 10.1016/j.jtho.2021.03.003. Epub 2021 Mar 23.

DOI:10.1016/j.jtho.2021.03.003
PMID:33771657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8159848/
Abstract
摘要